Dong-A Socio Holdings announced on the 23rd that it has received the highest rating of 'AA grade' among domestic pharmaceutical companies in the ESG (Environmental, Social, and Governance) evaluation conducted by Morgan Stanley Capital International (MSCI).


Exterior view of Dong-A Socio Holdings.

Exterior view of Dong-A Socio Holdings.

View original image

Since 1999, MSCI has been evaluating and publishing assessments of publicly listed companies worldwide based on 10 major areas and 35 key issues related to environmental, social, and governance factors. Dong-A Socio Holdings improved its rating every year, receiving a B grade in 2021, an A grade last year, and an AA grade in this latest evaluation.


In this evaluation, Dong-A Socio Holdings was highly rated for its policy establishment regarding anonymous reporting systems, ISO37001 certification management, business ethics education and internal audits, and human resource management.



A representative from Dong-A Socio Holdings stated, "Receiving a high ESG rating from a reputable global evaluation agency recognizes Dong-A Socio Holdings' efforts toward social responsibility management. We will continue to do our best to ensure that the entire group practices and leads as a company committed to social responsibility management."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing